Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BemPPOX
Cat. No.:
OB0425LY-045
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
BemPPOX is a novel small molecule with specific bioactivities targeting neurological related diseases and obesity.
Synonyms:
BemPPOX; 1998101-23-7
CAS No.:
1998101-23-7
Compound CID:
132838385
Formula:
C23H20N2O5
Formula Weight:
404.42
Specification
Target:
Lipase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
BemPPOX can be used to modulate gastrointestinal lipolysis and delay the overall lipolysis process in rats, with potential for obesity research.
